肺 premalignant 进展:非小细胞肺癌拦截的知识缺口与研究机会——ATS官方研究声明
美国胸科学会(ATS)组织国际多学科基础、转化与临床科学家团队,回顾现有数据并制定肺 premalignant 病变向晚期肺癌转化相关研究问题。声明指出肺 premalignant 进展的生物学机制、筛查、检测与早期干预存在显著知识缺口,强调需优先开展该领域研究以制定有效预防策略、降低肺癌发病率并改善患者结局。
要点
- 肺 premalignant 病变进展机制、筛查与早期干预存在显著知识缺口。
- 声明提出研究问题与优先研究方向,旨在探索肺癌早期拦截的创新模式。
- 需优先投入研究以制定有效预防策略,降低肺癌发病率并改善生存。
核心结论
- 肺 premalignant 进展的生物学机制及筛查、检测、早期干预存在显著知识缺口,应优先开展该领域研究以制定有效预防策略。
研究设计与样本
- ATS 官方研究声明,由国际多学科基础、转化与临床科学家团队回顾现有数据制定并细化研究问题。
主要发现
- 声明识别出肺 premalignant 病变向肺癌进展机制方面的显著知识缺口,并提出旨在扩展理解的研究问题。
- 声明提出探索在肺癌早期阶段拦截的潜在创新模式。
临床怎么用
- 为呼吸科及相关研究者提供肺 premalignant 进展与肺癌早期拦截的研究议题与优先方向参考。
局限性
- 本文为研究声明,识别知识缺口并提出研究问题,未报告具体研究数据或数值结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Despite significant advances in precision treatments and immunotherapy, lung cancer is the most common cause of cancer death worldwide. To reduce incidence and improve survival rates, a deeper understanding of lung premalignancy and the multistep process of tumorigenesis is essential, allowing timely and effective intervention before cancer development. Objectives: To summarize existing information, identify knowledge gaps, formulate research questions, prioritize potential research topics, and propose strategies for future investigations into the premalignant progression in the lung. Methods: An international multidisciplinary team of basic, translational, and clinical scientists reviewed available data to develop and refine research questions pertaining to the transformation of premalignant lung lesions to advanced lung cancer. Results: This research statement identifies significant gaps in knowledge and proposes potential research questions aimed at expanding our understanding of the mechanisms underlying the progression of premalignant lung lesions to lung cancer in an effort to explore potential innovative modalities to intercept lung cancer at its nascent stages. Conclusions: The identified gaps in knowledge about the biological mechanisms of premalignant progression in the lung, together with ongoing challenges in screening, detection, and early intervention, highlight the critical need to prioritize research in this domain. Such focused investigations are essential to devise effective preventive strategies that may ultimately decrease lung cancer incidence and improve patient outcomes.
引用
- Moghaddam SJ, Savai R, Salehi-Rad R, et al. Premalignant Progression in the Lung: Knowledge Gaps and Novel Opportunities for Interception of Non-Small Cell Lung Cancer. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2024. PMID: 39115548. doi:10.1164/rccm.202406-1168ST
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。